GlassScriptPhysician profile
Luke A Fisk
NPI 1538782396
$7,018.00
in general payments reported to CMS, 2019-2025
39 companies · $532 in 2025
The $532 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,503 · 2022: $1,858 · 2023: $1,516 · 2024: $608 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,656.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,495.95 | 2021-2025 | |
| Lilly USA, LLC | $1,134.14 | 2021-2024 | Mounjaro, Jardiance, Trulicity |
| Horizon Therapeutics Plc | $419.58 | 2021-2022 | |
| Novo Nordisk INC | $316.80 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Amarin Pharma, INC. | $275.48 | 2021-2023 | |
| Exact Sciences Corporation | $195.58 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $181.52 | 2021-2023 | Breztri |
| Pfizer INC. | $175.53 | 2021-2025 | |
| Daiichi Sankyo INC. | $171.14 | 2021-2024 | Injectafer |
| Biohaven Pharmaceutical Holding Company LTD. | $155.57 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $137.16 | 2021 | |
| Merck Sharp & Dohme LLC | $136.64 | 2021-2023 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Corcept Therapeutics | $107.68 | 2024-2025 | Korlym |
| Idorsia Pharmaceuticals US INC | $98.89 | 2022-2024 | Quviviq |
| Amgen INC. | $89.30 | 2021-2023 | Repatha, Otezla |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Fisk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.